Moderna skyrockets 39% after its early trial of a coronavirus vaccine produced antibodies in all 45 patie..

Stocks surge after Moderna announces promising early vaccine results"Sydney Morning HeraldModerna prices new shares at $76, expects to raise $1.34 billion"CNBCModerna shares jump 20pc on promising COVID-19 vaccine trial"The Australian Financial ReviewMode